New #1 Cause of Disease (Are YOU at risk?)
For years, heart disease has topped the list of killers worldwide.
We saw a dramatic increase in deaths from the disease between 2000 and 2019, climbing from TWO million to nearly NINE million deaths per year.
But while heart disease kills the most people, there’s another group of conditions that’s taken over as the number one cause of disease worldwide.
And there’s a good chance you are at risk…
A recent analysis revealed that 3.4 billion people—that’s a staggering 43 percent of the world’s population—suffered from some form of a neurological disorder in 2021.
With these new numbers, neurological conditions now TOP the list as the world’s leading cause of disease.
Various factors can be driving this steep rise. However, one reason the numbers are so high is that many different conditions fall under this neurological umbrella.
This broad category includes more than 37 sub-conditions, including dementia, Alzheimer’s, stroke, diabetic neuropathy, neonatal encephalopathy, migraine, meningitis, epilepsy, and even cognitive impairment from COVID-19.
The accelerated rise in neurological conditions over the past three decades—about 59 percent—is alarming.
Keeping track of this rise matters more than you might realize. After all, knowing what’s threatening us helps us all make informed decisions on how to live better AND longer.
As scientists search for cures, everyday folks like you and me can focus on the next best thing: prevention.
If you want to work on reducing your risk of developing a neurological condition, you can start with a few simple steps, such as managing blood pressure and blood sugar levels. Plus, if you drink, reduce the amount of alcohol you consume.
Before I go, I’d like to take a moment to wish you and yours a peaceful Good Friday.
P.S. Battling headaches? Try THIS easy timing trick. It could send that pain packing.
SOURCE:
“Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021,” The Lancet Neurology, Volume 23, ISSUE 4, P344-381, April 2024, doi. org/ 10.1016 /S1474-4422(24)00038-3
